301 related articles for article (PubMed ID: 31932911)
1. Clinical features and prognosis of late-onset neuromyelitis optica spectrum disorders in a Latin American cohort.
Carnero Contentti E; Daccach Marques V; Soto de Castillo I; Tkachuk V; Ariel B; Castillo MC; Cristiano E; Diégues Serva GB; Dos Santos AC; Finkelsteyn AM; López PA; Patrucco L; Molina O; Pettinicchi JP; Toneguzzo V; Caride A; Rojas JI
J Neurol; 2020 May; 267(5):1260-1268. PubMed ID: 31932911
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.
Seok JM; Cho HJ; Ahn SW; Cho EB; Park MS; Joo IS; Shin HY; Kim SY; Kim BJ; Kim JK; Cho JY; Huh SY; Kwon O; Lee KH; Kim BJ; Min JH
Mult Scler; 2017 Nov; 23(13):1748-1756. PubMed ID: 28058965
[TBL] [Abstract][Full Text] [Related]
3. Age of onset correlates with clinical characteristics and prognostic outcomes in neuromyelitis optica spectrum disorder.
Hu Y; Sun Q; Yi F; Yao L; Tian Y; Tang H; Luo M; Xie N; Wang Z; Liao X; Zhou L; Xu H; Zhou Y
Front Immunol; 2022; 13():1056944. PubMed ID: 36569880
[TBL] [Abstract][Full Text] [Related]
4. Age at onset predicts outcome in aquaporin-4-IgG positive neuromyelitis optica spectrum disorder from a United Kingdom population.
Papathanasiou A; Tanasescu R; Tench CR; Rocha MF; Bose S; Constantinescu CS; Jacob S
J Neurol Sci; 2021 Dec; 431():120039. PubMed ID: 34715481
[TBL] [Abstract][Full Text] [Related]
5. Late-onset neuromyelitis optica spectrum disorder: The importance of autoantibody serostatus.
Sepulveda M; Delgado-García G; Blanco Y; Sola-Valls N; Martinez-Lapiscina EH; Armangué T; Montejo C; Pulido-Valdeolivas I; Martinez-Hernandez E; Ariño H; Escudero D; Ruiz-García R; Llufriu S; Dalmau J; Graus F; Saiz A
Neurol Neuroimmunol Neuroinflamm; 2019 Nov; 6(6):. PubMed ID: 31471461
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome and prognosis in patients with neuromyelitis optica spectrum disorder from Serbia.
Drulovic J; Martinovic V; Basuroski ID; Mesaros S; Mader S; Weinshenker B; Pekmezovic T
Mult Scler Relat Disord; 2019 Nov; 36():101413. PubMed ID: 31586803
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of very late-onset neuromyelitis optica spectrum disorder.
Cai LJ; Zhang Q; Zhang Y; Chen HX; Shi ZY; Du Q; Zhou HY
Mult Scler Relat Disord; 2020 Nov; 46():102515. PubMed ID: 33032051
[TBL] [Abstract][Full Text] [Related]
8. Late onset neuromyelitis optica spectrum disorder with anti-aquaporin 4 and anti-myelin oligodendrocyte glycoprotein antibodies.
Wang L; Tan H; Huang W; Chang X; ZhangBao J; Zhou L; Lu C; Wang M; Lu J; Zhao C; Quan C
Eur J Neurol; 2022 Apr; 29(4):1128-1135. PubMed ID: 34967093
[TBL] [Abstract][Full Text] [Related]
9. Brain magnetic resonance imaging features in multiple sclerosis and neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody in a Latin American population.
Silveira F; Pappolla A; Sánchez F; Marques VD; de Castillo IS; Tkachuk V; Caride A; Castillo MC; Cristiano E; Cruz CA; Diégues Serva GB; Dos Santos AC; Moreira CL; López PA; Patrucco L; Molina O; Pettinicchi JP; Carnero Contentti E; Rojas JI
Mult Scler Relat Disord; 2020 Jul; 42():102049. PubMed ID: 32251869
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder.
Min W; Zhang L; Wang S; Xue M; Guo C; Zhu M
Mult Scler Relat Disord; 2023 Feb; 70():104517. PubMed ID: 36708681
[TBL] [Abstract][Full Text] [Related]
11. Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
Collongues N; Marignier R; Jacob A; Leite MI; Siva A; Paul F; Zephir H; Akman-Demir G; Elsone L; Jarius S; Papeix C; Mutch K; Saip S; Wildemann B; Kitley J; Karabudak R; Aktas O; Kuscu D; Altintas A; Palace J; Confavreux C; De Seze J
Mult Scler; 2014 Jul; 20(8):1086-94. PubMed ID: 24323817
[TBL] [Abstract][Full Text] [Related]
12. Application of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorders in a cohort of Latin American patients.
Carnero Contentti E; Soto de Castillo I; Daccach Marques V; López PA; Antunes Barreira A; Armas E; de Aquino Cruz C; Rubstein A; Lavigne Moreira C; Molina OM; Soto A; Tkachuk V
Mult Scler Relat Disord; 2018 Feb; 20():109-114. PubMed ID: 29367170
[TBL] [Abstract][Full Text] [Related]
13. Very late onset neuromyelitis optica spectrum disorders.
Nakahara K; Nakane S; Nagaishi A; Narita T; Matsuo H; Ando Y
Eur J Neurol; 2021 Aug; 28(8):2574-2581. PubMed ID: 33960076
[TBL] [Abstract][Full Text] [Related]
14. Neuromyelitis Optica spectrum disorders in Argentina: A hospital-based study.
Villa AM; Manin A; Seimandi C; Finkelsteyn AM; Ramos G; Tenembaum S
Mult Scler Relat Disord; 2023 Nov; 79():105018. PubMed ID: 37806234
[TBL] [Abstract][Full Text] [Related]
15. Acute optic nerve lesions in first-ever NMOSD-related optic neuritis using conventional brain MRI: A Latin American multicenter study.
Carnero Contentti E; Delgado-García G; López PA; Criniti J; Pettinicchi JP; Correa-Díaz EP; Soto de Castillo I; Daccach Marques V; Tkachuk V; Cristiano E; Serva Braga Diéguez G; Dos Santos AC; Castillo MC; Patrucco L; Álvarez Pucha MO; Miño Zambrano JE; Gómez-Figueroa E; Rivas-Alonso V; Flores-Rivera J; Caride A; Rojas JI
Mult Scler Relat Disord; 2020 Nov; 46():102558. PubMed ID: 33032052
[TBL] [Abstract][Full Text] [Related]
16. Neuromyelitis optica spectrum disorders with and without associated autoimmune diseases.
Carnero Contentti E; López PA; Pettinicchi JP; Tkachuk V; Daccach Marques V; de Castillo IS; Cristiano E; Patrucco L; Caride A; Rojas JI
Neurol Sci; 2023 May; 44(5):1731-1737. PubMed ID: 36645533
[TBL] [Abstract][Full Text] [Related]
17. Epidemiological findings of neuromyelitis optica spectrum disorders in a Venezuelan study.
Ibis SC; Omaira M; Arnoldo S; Elizabeth A; Sandra M; Carlota CM; Elizabeth C; Laura V; Rosalba L; Oscar V; Luisa DM; Nahir A; Hernandez F
Mult Scler Relat Disord; 2021 Jan; 47():102652. PubMed ID: 33279797
[TBL] [Abstract][Full Text] [Related]
18. Neuromyelitis optica spectrum disorders with a benign course. Analysis of 544 patients.
Lana-Peixoto MA; Talim NC; Callegaro D; Marques VD; Damasceno A; Becker J; Gonçalves MVM; Sato H;
Mult Scler Relat Disord; 2023 Jul; 75():104730. PubMed ID: 37156036
[TBL] [Abstract][Full Text] [Related]
19. Late-onset neuromyelitis optica spectrum disorder in AQP4-seropositivepatients in a Chinese population.
Mao Z; Yin J; Zhong X; Zhao Z; Qiu W; Lu Z; Hu X
BMC Neurol; 2015 Sep; 15():160. PubMed ID: 26337073
[TBL] [Abstract][Full Text] [Related]
20. An Abnormally High Neutrophil-to-Lymphocyte Ratio Is Not an Independent Outcome Predictor in AQP4-IgG-Positive NMOSD.
Carnero Contentti E; Delgado-García G; Criniti J; López PA; Pettinicchi JP; Cristiano E; Miguez J; Correa-Díaz EP; Álvarez Pucha MO; Miño Zambrano JE; Gómez-Figueroa E; Rivas-Alonso V; Flores-Rivera J; Tkachuk V; Caride A; Rojas JI
Front Immunol; 2021; 12():628024. PubMed ID: 33717149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
